Pring Turner Capital Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$399K Hold
371
0.24% 49
2025
Q4
$399K Sell
371
-5
-1% -$4.78K 0.25% 48
2025
Q3
$287K Sell
376
-13
-3% -$9.67K 0.18% 55
2025
Q2
$303K Hold
389
0.2% 54
2025
Q1
$321K Sell
389
-15
-4% -$12.5K 0.2% 50
2024
Q4
$312K Sell
404
-143
-26% -$118K 0.21% 52
2024
Q3
$485K Sell
547
-51
-9% -$45.9K 0.31% 47
2024
Q2
$541K Sell
598
-50
-8% -$40K 0.38% 45
2024
Q1
$504K Sell
648
-10
-2% -$7.12K 0.37% 43
2023
Q4
$384K Sell
658
-70
-10% -$40.9K 0.29% 47
2023
Q3
$391K Buy
728
+84
+13% +$43.3K 0.33% 47
2023
Q2
$302K Hold
644
0.28% 51
2023
Q1
$221K Hold
644
0.22% 57
2022
Q4
$236K Buy
+644
New +$228K 0.26% 55
2014
Q1
Sell
-1,450
Closed -$74K 108
2013
Q4
$74K Buy
+1,450
New +$72.6K 0.07% 72

Other funds holding LLY

Pring Turner Capital Group's LLY Position: Q1 2026 in Review

Pring Turner Capital Group held its Eli Lilly (LLY) position steady in Q1 2026 at 371 shares worth $399K. The position accounts for 0.24% of the portfolio, ranked #49.

Pring Turner Capital Group first reported a position in LLY in Q4 2013 and has held it in 15 quarters since. The position peaked at $541K in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pring Turner Capital Group held 371 shares of Eli Lilly worth $399K as of Q1 2026.
  • Pring Turner Capital Group left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.24% of Pring Turner Capital Group's portfolio in Q1 2026, its #49 holding.
  • Pring Turner Capital Group first reported a position in Eli Lilly in Q4 2013 and has held it in 15 quarters since.
  • Pring Turner Capital Group's Eli Lilly position peaked at $541K in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pring Turner Capital Group's 13F filing for Q1 2026, filed 13 May 2026.